<DOC>
	<DOCNO>NCT02024191</DOCNO>
	<brief_summary>Oxaliplatin chemotherapeutic agent , generally use treatment colorectal cancer . The dose limiting side effect oxaliplatin neurotoxicity . In study aim determine whether glutamine role prevention oxaliplatin induce neuropathy .</brief_summary>
	<brief_title>The Role Glutamine Preventing Oxaliplatin-Induced Peripheral Neuropathy</brief_title>
	<detailed_description>Our study population include colorectal cancer patient go mFOLFOX6 ( modify , Folinic acid 400 mg/m2 1 day , oxaliplatin 85 mg/m2 1 day , 5-fluorouracil l 400 mg/m2 bolus 2400 mg/m2 continuous infusion 48 hour ) regimen . We randomly assign patient two group . We administer glutamine dose 3x10 gr/day one patient group concomitantly mFOLFOX6 regimen group additional intervention . We perform questionnaire , neurological examination EMG ( Electromyography ) 4th cycle mFOLFOX6 regimen patient group . We plan compare neurological sign , symptom EMG action potential mFOLFOX6+Glutamine mFOLFOX6 group . We aim search role glutamine prophylactic agent oxaliplatin induce neuropathy .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Age 20 65 year Operated non operated colorectal cancer patient Patient administer mFOLFOX 6 ( Folinic acid 400 mg/m2 1 day , oxaliplatin 85 mg/m2 1 day , 5fluorouracil 400 mg/m2 bolus 2400 mg/m2 continuous infusion 48 hour ) Patients chemotherapy last 6 month Diabetes Mellitus Sensorimotor polyneuropathy Anemia</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>glutamine</keyword>
	<keyword>oxaliplatin</keyword>
	<keyword>peripheral neuropathy</keyword>
</DOC>